drugset / Trial / NCT03544606
Nitric Oxide Donor Isosorbide Mono Nitrate for Cervical Ripening in Induction of Labor
RandomizedParallel-groupDouble-blindSupportive care
Summary
The study aims to evaluate and assess the effectiveness and safety of vaginal administration of isosorbide mono nitrate (IMN) to induce cervical ripening and shorten the interval time between induction and delivery in women undergoing induction of labor. Research Hypothesis: In women undergoing induction of labor, vaginal administration of isosorbide mono nitrate (IMN) is effective to induce cervical ripening and shorten the interval time between induction and delivery. Research Questions: Does vaginal administration of isosorbide mono nitrate (IMN) induce cervical ripening and shorten the interval time between induction and delivery in women undergoing induction of labor?
Timeline
- Start
- 2023-12-01
- Primary completion
- 2024-06-15
- Completion
- 2024-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Isosorbide Mononitrate | Other / unclassified | 40 mg | Other |
Indications
No indication recorded.